Shionogi
OTC: SGIOF2 known investors
Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19. It works to address global health challenges such as antimicrobial resistance, partnering with industry, government agencies, and early-stage biotechs.
Investors · 2
Competitors · 2
by search overlap
Medscape90 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Globaldata63 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies competing with Shionogi for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Shionogi do?
- Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19. It works to address global health challenges such as antimicrobial resistance, partnering with industry, government agencies, and early-stage biotechs.
- Who are Shionogi's investors?
- Shionogi's investors include Advent Life Sciences, Solas BioVentures.